WELCOME MESSAGE

BRAIN 2022 - the 18th Multidisciplinary Meeting for Nervous System Diseases, is jointly organized by Division of Neurology, Neuropathology and Division of Neurosurgery, The Chinese University of Hong Kong (CUHK), we are committed to advance neurological science by promoting in-depth communication among all local and overseas neurologists, neurosurgeons, pathologists, clinical and preclinical scientists and related healthcare professionals.

We strive to bring all participants a great line-up of discussion on Parkinson’s Disease, Alzheimer’s Disease, Stroke, and Brain Tumours.

New place, new experience
We welcome all Hong Kong-based guests in person at CUHK Medical Centre, the new private teaching hospital wholly owned by CUHK, while overseas guests can join us online from anywhere around the globe.

Come and join us in this exciting event and share the passion on advancing knowledge and gaining new insights.



Organisers

Division of Neurology
Neuropathology
Division of Neurosurgery
The Chinese University of Hong Kong

Supporting Organisations

Hong Kong Neurological Society
Hong Kong Neuro-oncology Society
The Hong Kong Neurosurgical Society
The Hong Kong Neurosurgical Society (Nursing Chapter)
Hong Kong Student Association of Neuroscience
International Academy of Pathology, Hong Kong Division

FACULTY
(in alphabetical order)


 X
Martin J. van den BENT
Professor of Neuro-oncology
Brain Tumor Center at the Erasmus MC Cancer Institute
University Medical Center Rotterdam, Rotterdam, The Netherlands

Martin J. van den BENT
Brain Tumor Center at the Erasmus MC Cancer Institute
University Medical Center Rotterdam
 X
Danny Tat-Ming CHAN
Consultant
Division of Neurosurgery
Department of Surgery
The Chinese University of Hong Kong, Hong Kong

Danny is a medical graduate at The Chinese University of Hong Kong (CUHK). He completed his specialist training in Neurosurgery in 2004 and was awarded the Douglas Miller Gold Medal for distinction in Neurosurgery by The College of Surgeons of Hong Kong and The Royal College of Surgeons, Edinburgh. He received his overseas training for Neuro-Oncology in MD Anderson Cancer Centre under the mentorship of Professor Alfred Wai-Kwan Yung in 2007.

Danny is currently Honorary Clinical Associate Professor and the Head of the Division of Neurosurgery at Department of Surgery, Prince of Wales Hospital (PWH) / CUHK, and Associate Director of the CUHK Otto Wong Brain Tumour Centre. His special interests include Neuro-Oncology, glioma surgery and functional Neurosurgery. In 2009. He and his team established the first one-stop multidisciplinary combined neuro-oncology clinic (CNO) for management of brain tumour patients in Hong Kong. They also introduced awake cortical mapping and fluorescence guided surgery for the management of gliomas. Danny is the founding organiser of the "Hong Kong - Walk around the World for Brain Tumours" Awareness Program (since 2007).

Danny Tat-Ming CHAN
Division of Neurosurgery, Department of Surgery
Prince of Wales Hospital/
The Chinese University of Hong Kong
 X
Kannie Wai-Yan CHAN
Associate Professor
Department of Biomedical Engineering
City University of Hong Kong, Hong Kong

Dr. Kannie Wai-Yan CHAN's research focuses on the development of biomaterials and imaging approaches to facilitate the clinical translation of cancer therapy and cell therapy, and early diagnosis of neurodegenerative diseases. She received her BSc and PhD degrees from The University of Hong Kong. She completed post-doctoral fellowships in magnetic resonance imaging (MRI) at Department of Radiology, Johns Hopkins University School of Medicine, and became an Assistant Professor in 2014. She joined City University of Hong Kong in 2016. She is a leading researcher in applying a frontier molecular MRI contrast mechanism to address clinical needs, which is known as chemical exchange saturation transfer (CEST). She has pioneered the imaging of glucose utilization in the brain using CEST-MRI. The way how our brain uses glucose could have implications on diagnosis and therapy in many neurological disorders, including Alzheimer's disease and stroke. Her team is developing various techniques to effectively image and deliver drugs/cells in the brain non-invasively. She published over 60 peer-reviewed articles, including a cover article in Nature Materials, Science Advances, Theranostics and Nature Communications. She is a corporate member of HKIE, an adjunct faculty of Johns Hopkins University School of Medicine, and an associate director of COCHE. She served as AMPC member of ISMRM and is now at the publication committee of ISMRM

Kannie Wai-Yan CHAN
Department of Biomedical Engineering
City University of Hong Kong

 X
Shin-Yuan CHEN
Professor of Neurosurgery
Institute of Medical Sciences, Tzu Chi University
Department of Neurosurgery, Hualien Tzu Chi Hospital
Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan

Shin-Yuan CHEN
Institute of Medical Sciences, Tzu Chi University
Department of Neurosurgery, Hualien Tzu Chi Hospital
Buddhist Tzu Chi Medical Foundation
 X
Carol Yim-Lui CHEUNG
Associate Professor
Department of Ophthalmology and Visual Sciences
The Chinese University of Hong Kong, Hong Kong

Dr. Carol Yim-Lui CHEUNG is an Associate Professor at Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong. Dr Cheung's main research interest is "imaging of the eye", based on the concept that the eyes are the "window" to the human circulation and nervous systems. She has been working in the field of ocular imaging for more than 15 years in Hong Kong and in Singapore, focus on development and application of image analysis techniques and artificial intelligence for studying diabetic retinal disease, glaucoma and Alzheimer's disease. She is now focused on translating her artificial intelligence-related research from "bench" to "bedside", with an aim to enhance eye and brain diseases screening in primary care, and eye disease triaging in tertiary clinics, for timely disease management and treatment. This will bring significant societal impact by improving quality and efficiency of the clinical service in Hong Kong and beyond the region. Dr Cheung has authored more than 240 original research articles, 9 commentary or editorial articles and 25 review articles in SCI international indexed peer reviewed journals, and 14 book chapters. She has published several landmark papers on development of AI-based technologies in ocular imaging for detection of multiple eye diseases, and using retinal imaging to study Alzheimer's disease, with an H-index of 54 and citations >9,800 (Scopus).

Carol Yim-Lui CHEUNG
Department of Ophthalmology and Visual Sciences
The Chinese University of Hong Kong
 X
Xiaoling HU
Associate Professor
Department of Biomedical Engineering
The Hong Kong Polytechnic University, Hong Kong

Xiaoling HU
Department of Biomedical Engineering
The Hong Kong Polytechnic University

 X
Thomas HUMMEL
Professor
Department of Otorhinolaryngology
Technical University of Dresden, Dresden, Germany

Professor Hummel obtained his medical degree (1986) from University of Erlangen-Nürnberg, Germany. He received his fellowship training in pharmacology at University of Iowa in USA (1992-93) and went through a special programme (Habilitation) in Pharmacology and Toxicology at University of Erlangen-Nürnberg (1996). He was Assistant Professor at Department of Otorhinolaryngology of University of Iowa in 1996. On his return since 1998 he has been appointed as Professor at Department of Otorhinolaryngology of Technical University of Dresden, Germany. For his outstanding work in chemosensory systems, he was awarded Takasago Award for excellence in Chemorecption Sciences (1996), Alexander von Humboldt prize from the FNRS Fonds de la Recherche Scientifique, Brussels (2009) and “Professor Dr. Ludwig-Haymann-Preis” of the German ENT Society (2018).

Professor Hummel has published over 750 articles in peer-reviewed journals for a total of 45,800 citations and with an h-index of 105. He is a member of Editorial Boards of internationally recognised journals including European Archives of Otorhinolaryngology, Chemosensory Perception, Allergy & Rhinology, PLoS One, HNO, and ORL (Karger). He is member of European Chemoreception Research Organization, Association for Chemoreception Sciences, International Association for the Study of Pain, American Society for Neuroscience and Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde (German Society for Ear, Nose and Throat Medicine).

Thomas HUMMEL
Department of Otorhinolaryngology
Technical University of Dresden
 X
Bonaventure Yiu-Ming IP
Clinical Lecturer
Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong, Hong Kong

Dr. Bonaventure IP obtained his Bachelor of Medicine and Bachelor of Surgery (MBChB) from The Chinese University of Hong Kong. He is a neurology specialist serving as a clinical lecturer at the Faculty of Medicine, CUHK. Dr. Ip's expertise covers cerebrovascular disease prevention, diagnostics and intervention, he is also a core member of the endovascular neurointervention team of the Prince of Wales Hospital. Dedicated to research and education, Dr. Ip had authored multiple peer-reviewed publications, received the best dissertation award in the 32nd Hong Kong Neurological Society Annual Scientific Meeting (2019) and has been elected as an exemplary teacher and best teacher multiple times by the Faculty.

Bonaventure Yiu-Ming IP
Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
 X
Clifford R. Jack
Consultant
Department of Radiology
Mayo Clinic, Minnesota, USA

The laboratory of Clifford R. Jack Jr., M.D., is engaged in brain imaging research in cognitive aging, Alzheimer's disease and related disorders. Dr. Jack's research team employs MRI and positron emission tomography (PET) to study the biology of brain aging and causes of cognitive impairment and develops image-processing algorithms for quantitatively measuring the information obtained from brain imaging. They employ a variety of MRI-based brain imaging modalities, including structural MRI, spectroscopy, functional connectivity and brain water diffusion. They also employ F-fluorodeoxyglucose positron emission tomography (FDG-PET) and amyloid PET. The lab's clinical imaging research is tightly integrated into the Mayo Clinic Alzheimer's Disease Patient Registry (Mayo Clinic Study of Aging) and Mayo's Alzheimer's Disease Research Center, which conduct National Institutes of Health-funded longitudinal clinical and epidemiological research projects investigating normal aging, Alzheimer's disease and other dementias. Dr. Jack also collaborates with a number of investigators outside Mayo, and his laboratory is the imaging center for several large national multisite studies.

Clifford R. Jack
Aging and Dementia Imaging Laboratory
Mayo Clinic, Minnesota

 X
Paul S. LARSON
Professor and Vice Chair
Department of Neurological Surgery
University of California, San Francisco, California, USA

Paul S. LARSON
Department of Neurological Surgery
University of California
 X
Cindy Xinyi LENG
Assistant Professor
Division of Neurology
Department of Medicine & Therapeutics
The Chinese University of Hong Kong, Hong Kong

Dr. Cindy LENG's research focuses on stroke and intracranial atherosclerotic disease (ICAD). In the past few years, Dr. Leng has been utilizing multimodal neuroimaging and computational methods to study cerebral hemodynamics and plaque characteristics in ICAD and its clinical implications, using a cross-disciplinary approach. She also works on the efficacy and safety of medical and interventional treatment regimens in ischemic stroke, and investigates mechanisms of collateral circulation recruitment and its prognostic values in stroke patients. In these research areas, she has close collaboration with University of Oxford, University of California Los Angeles, Beijing Tiantan Hospital of Capital Medical University, and Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences.

Dr. Leng has been funded by the Research Grants Council of Hong Kong, the Health and Medical Research Fund, National Natural Science Foundation of China, China Association for Science and Technology, World Heart Federation, and the Lee Hysan Postdoctoral Fellowship in Clinical Neurosciences. Since 2013, Dr. Leng has published more than 60 peer-reviewed articles in international academic journals, including Circulation, Annals Neurology, Neurology, J Neurol Neurosurg Psychiatry, Stroke, with an h-index of 18. She is an Associate Editor of Stroke and Vascular Neurology (official journal of Chinese Stroke Association), and serves on the Editorial Board of Stroke (official journal of American Heart Association) and International Journal of Stroke (official journal of World Stroke Organization).

Cindy Xinyi LENG
Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
 X
Luming LI
Executive Dean and Professor
School of Aerospace Engineering
Tsinghua University
Department of Aeronautics & Astronautics, Beijing, China

Luming LI
School of Aerospace Engineering
Tsinghua University
Department of Aeronautics & Astronautics

 X
Yongjie LI
Professor and Director
Centre of Neuro-medicine
The University of Hong Kong - Shenzhen Hospital, Shenzhen, China

Yongjie LI
Centre of Neuro-medicine
The University of Hong Kong - Shenzhen Hospital
 X
Vincent Chung-Tong MOK
Endowed Mok Hing Yiu Professor of Medicine
Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong, Hong Kong

Professor Vincent C.T. MOK 's research aims to understand mechanisms of dementia and to investigate strategies that may help to prevent dementia. He is the first to report the association of cerebral small vessel disease (CSVD) and cognitive impairment in Asia and the first to report the community prevalence of CSVD among Asians (Chinese). Such findings have significantly increased the awareness that strategies targeting CSVD (e.g. blood pressure lowering) can help to prevent dementia in this region, where the burden of dementia is particularly huge. Prof. Mok conducted one of the largest single-centre studies investigating the prevalence and mechanisms of early and delayed cognitive decline in the context of stroke and found that concurrent presence of amyloid plaques as detected by in-vivo amyloid PET imaging and CSVD are important factors associated with early and delayed cognitive decline after stroke, respectively. Such findings provide a road map of how to prevent vascular cognitive impairment. Prof. Mok, along with Dr Adrian Wong (Clinical Psychologist) validated the Hong Kong-Montreal Cognitive Assessment (HK-MoCA) and developed norms for HK-MoCA performance according to age and education. HK-MoCA is currently the commonest brief cognitive assessment used for the assessment of cognitive function and the detection of mild cognitive impairment in HK.

Prof. Mok has been involved in the validation and clinical application of a novel Machine-Learning MRI-based Index, which was developed by a spin-off company of the Chinese University of Hong Kong (CUHK), for the detection of early Alzheimer's disease. Such technology provides an easy screening method for early Alzheimer's disease among subjects with mild cognitive impairment. Moreover, he also specializes in Parkinson's disease and was one of the pioneers of developing Deep Brain Stimulation programme in Asia for the treatment of Parkinson's disease. He received the Higher Education Outstanding Scientific Research Output Award (Science & Technology) in Natural Sciences (1st Class) from the Ministry of Education, People's Republic of China in 2011 for his research in cerebrovascular disease, Outstanding Fellow Award from the Faculty of Medicine of CUHK for his exceptional academic leadership in areas of research, education and service in 2016, Endowment as Mok Hing Yiu Professor of Medicine by CUHK in 2017, and the Excellent Research Award from the Food and Health Bureau of the Hong Kong Special Administrative Region for his research in vascular cognitive impairment in 2017. He received 7 times Teacher of the Year Award and the Master Teacher Award from the Faculty from the Faculty of Medicine, CUHK.

Prof. Mok has authored more than 300 publications in peer-reviewed international journals (with book chapters), with publications at Lancet, JAMA, Lancet Neurology, Nature Reviews Neurology, Alzheimer's & Dementia, JAMA Neurology, JAMA Psychiatry, Journal of Neurology, Neurosurgery and Psychiatry (JNNP), Annals of Neurology, Neurology and Stroke.

Vincent Chung-Tong MOK
Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
 X
Ho-Keung NG
Professor
Department of Anatomical and Cellular Pathology
The Chinese University of Hong Kong, Hong Kong

H.K. is Chair Professor at CUHK. His interests are in the molecular pathology of brain tumours, both adult and paediatric. H.K. is both a neuropathologist and general pathologist. He is an Associate Editor of Laboratory Investigation and an Associate Editor of Neuro-Oncology Advances, and is also on the Editorial Boards of Acta Neuropathologica, Brain Pathology, Neuropathology and Applied Neurobiology, Clinical Neuropathology, Pathology and International Journal of Clinical and Experimental Pathology. He was a member of the Consensus Group of the 2007 and 2016 WHO classifications of the brain tumours. And for the upcoming WHO 2020, he is one of the only 10 neuropathologists from around the world selected to make up the Consensus Group.

H.K. was part of the team who received The 2nd Tier Prize of The National Science and Technology Award of China in 2010 and the First Tier Prize of the Science and Technology Award of Shanghai in 2019. He received The International Academy of Pathology Gold Medal twice in 2006 and 2017.

Ho-Keung NG
Department of Anatomical and Cellular Pathology
The Chinese University of Hong Kong

 X
Wai-Sang POON
Emeritus Professor
Division of Neurosurgery
Department of Surgery
The Chinese University of Hong Kong, Hong Kong

Wai is a Glasgow medical graduate of 1978 and trained in Neurosurgery at Glasgow's Institute of Neurological Sciences [1983-1986]. He did his research fellowship at Department of Neurosurgery, Massachusetts General Hospital/ Harvard Medical School in 1990-1991. He has joined The Chinese University of Hong Kong (CUHK)/ Prince of Wales Hospital (PWH) as a faculty member in academic neurosurgery since 1986 and became Chief in Neurosurgery [1988-2019] and Chair Professor in 2003. He is currently Emeritus Professor and Clinical Professional Consultant, and Director of the CUHK Otto Wong Brain Tumour Centre.

Wai has a strong interest in clinical and experimental head injury, and more recently cell therapy, cell biology in brain tumours and axonal injury in central nervous system. He has the expertise and motivation to do prospective clinical studies as Principle Investigator in brain injuries. He is author of 450 peer-reviewed publications.

Wai is an active participant of college and society activities locally and internationally. He has been doing medico-legal work since 1992. He is active in undergraduate and postgraduate surgical education, and specialist training in Neurosurgery, as Vice President [Internal Affairs] of The College of Surgeons of Hong Kong (CSHK), Chief Examiner for Neurosurgery and Past Chairman of the Neurosurgery Board [2007-2019] of the CSHK.

Wai-Sang POON
Division of Neurosurgery, Department of Surgery
Prince of Wales Hospital/ The Chinese University of Hong Kong
 X
Vinay K. PUDUVALLI
Professor and Chair
Department of Neurooncology
The University of Texas M. D. Anderson Cancer Center, Houston, USA

Vinay K. PUDUVALLI
Department of Neurooncology
The University of Texas M. D. Anderson Cancer Center
 X
Filip SCHEPERJANS
Attending Neurologist
Clinical Research Group Leader
Department of Neurology
Helsinki University Hospital, Helsinki, Finland

Dr. Filip SCHEPERJANS, MD, studied medicine at the University of Düsseldorf (Germany) and gained international experience as a visiting student in London, New York, and Helsinki. His doctoral thesis in the field of neuroanatomy under Prof. Karl Zilles (C & O Vogt Institute for Brain Research, University of Düsseldorf and Institute of Medicine, Research Center Jülich, Germany) was awarded the best medical thesis of the University of Düsseldorf in 2008. Now living in Finland, he works as attending neurologist and clinical research group leader at the Department of Neurology of Helsinki University Hospital. He is adjunct professor of neurology at the University of Helsinki and his clinical and research focus are movement disorders. He pioneered the research on gut microbiota in Parkinson’s disease through the first publication ever to assess gut microbiota composition in Parkinson’s vs. control subjects. Since then, he has published numerous high impact papers further elucidating how gut microbiota interact with the host and impact Parkinson’s symptoms and progression. His research group is currently conducting a first randomized double-blind controlled trial of fecal microbiota transplantation in PD. His work has led to several patents that are currently the basis for the development of next generation bacterial diagnostics and treatments for Parkinson’s through his company NeuroBiome Ltd. For his groundbreaking work in this field, he was awarded the Uschi Tschabitscher Prize for Young Neurologists by the European Academy of Neurology in 2014, the young researcher award of the Finnish Neurological Society in 2019, and the Research Prize of the Wilhelm and Else Stockmann Foundation in 2021.

Filip SCHEPERJANS
Department of Neurology
Helsinki University Hospital

 X
Jiguang WANG
Padma Harilela Associate Professor of Life Science
Division of Life Science & Department of Chemical & Biological Engineering
The Hong Kong University of Science & Technology, Hong Kong

Jiguang WANG
Division of Life Science & Department of Chemical & Biological Engineering
The Hong Kong University of Science & Technology
 X
Yun Kwok WING
Professor (Clinical) & Chairman
Department of Psychiatry
The Chinese University of Hong Kong, Hong Kong

Prof. Yun Kwok WING graduated from The Chinese University of Hong Kong, Hong Kong SAR, China. He is currently the Chairman and Professor in the Department of Psychiatry of the Faculty of Medicine of the Chinese University of Hong Kong. He is also the Director of the Li Chiu Kong Family Sleep Assessment Unit of The Chinese University of Hong Kong.

Professor Wing has diverse research interest in sleep and circadian medicine, psychiatric disorders, neuropsychiatry, and transcultural psychopharmacology. He has active contribution to the scientific communities, including his leadership role in the Hong Kong Society of Sleep Medicine (ex-President, HKSSM) and Asian Sleep Society of Sleep Medicine (ASSM, Vice-president of Education). He was also involved in the World Association of Sleep Medicine (Scientific Committee, 2011, 2013 and 2015), World Sleep 2017, 2019 and 2022 (Scientific Committee). He has recently organised and chaired the Gordon Research conference on the "Cognitive Dysfunction in Brain diseases" in Hong Kong May 2019. He is currently serving at 6 editorial boards including his role as Associate Editor in the journal 'Behavioral Sleep Medicine' and Deputy Editor in 'Sleep Medicine Research'.

He and his research group has established the first local epidemiological data of various sleep disorders including sleep deprivation, insomnia, narcolepsy, and parasomnia. In particular, the group has studied interaction of sleep and circadian propensity with psychiatric disorders and has recently completed a study on using bright light adjuvant treatment to manage patients with depression and evening chronotype. The group has also completed a novel prevention study of insomnia among at-risk adolescents. In addition, the group has extensive work on REM Sleep behavioral disorder, a sleep disorder with high specificity in predicting future alpha-synucelinopathy neurodegeneration. Our recent familial RBD study suggested a strong familial aggregation and staging pathology of alpha-synucleinopathy. The group is working on the brain-gut hypothesis at which the microbiota may have a significant role in predisposing to future synucleinopathy as well as the close relationship among psychiatric disorders, RBD and alpha-synucleinopathy.

Professor Wing was awarded the distinguished national award for Sleep Medicine Scientific Technological Advance in China by the Chinese Medical Doctor Association at 2010 and distinguished contributions to the development of sleep medicine and sleep research by Chinese Sleep Research Society at 2016. He was also awarded the Teacher of the Year Awards, Faculty of Medicine, CUHK in 2012-13.

Yun Kwok WING
Department of Psychiatry
The Chinese University of Hong Kong
 X
Angela Ruohao WU
Assistant Professor
Division of Life Science & Department of Chemical & Biological Engineering
The Hong Kong University of Science & Technology, Hong Kong

Angela Ruohao WU
Division of Life Science & Department of Chemical & Biological Engineering
The Hong Kong University of Science & Technology

 X
Hannah Hong XUE
Professor Emeritus
Adjunct Professor
Division of Life Science and Institute for the Environment & HKUST Fok Ying Tung Graduate School
The Hong Kong University of Science & Technology, Hong Kong

Hannah Hong XUE
Division of Life Science and Institute for the Environment & HKUST Fok Ying Tung Graduate School
The Hong Kong University of Science & Technology




More to come ......

PROGRAMME

Time / Date 24 Feb 2022 (Thursday) 25 Feb 2022 (Friday) 26 Feb 2022 (Saturday)
0800-0830   Registration
0830-0900
0900-0930 Stroke
(Auditorium)
Alzheimer's Disease
Brain Tumours II
(Auditorium)
0930-1000
1000-1030
1030-1100 Intermission
1100-1130 Brain Tumours I
(Auditorium)
Intermission
1130-1200 Poster Presentation
Parkinson's Disease - DBS System & Technology
(Auditorium)
1200-1230
1230-1300
1300-1330 Intermission
1330-1400 Intermission
1400-1430 Satellite Symposium
Hong Kong Student Association of Neuroscience
Mr Otto Lien Da Wong Visiting Professorial Lecture in Neuro-Oncology
(Auditorium)
1430-1500 Parkinson's Disease - Pre-motor Symptoms
(Auditorium)
1500-1530
1530-1600  
1600-1630 Intermission
1630-1700 Parkinson's Disease - Evolving Technology of DBS
(Auditorium)
1700-1730  
1730-1800
1800-1830
25 Feb 2022 (Friday)

26 Feb 2022 (Saturday)

Poster Presentation
EVALUATING EFFECTIVENESS OF MUSIC GROUP IN IMPROVING ATTENTION AND MOOD IN ATTENTION-IMPAIRED PATIENTS IN LOCAL GERIATRIC DAY HOSPITAL SETTING
King Ho CHAN
PREDICTIVE VALUE OF WADA TEST ON POST-OPERATIVE VERBAL MEMORY IN CHINESE PATIENTS: A CASE STUDY
Samara HUSSAIN
THE EFFECT OF ACUPRESSURE IN THE TREATMENT OF NON-MOTOR SYMPTOMS IN PARKINSON’S DISEASE: A PILOT CLINICAL STUDY
Hong Yi Justin LAI

REGISTRATION

Free Registration
In order to make BRAIN 2022 more accessible, this year's conference is free to attend. Don't miss the chance to interact face-to-face and online with the experts.

Your health and safety is our priority
To safeguard the health, safety and wellbeing of the speakers, delegates and sponsors at BRAIN 2022, we are closely monitoring the overall COVID-19 situation. We will consider to change the conference in virtual format subject to pandemic control. Please stay tuned to our website and pay attention to the latest announcement.

ABSTRACTS

Authors are invited to submit abstracts on any clinical, experimental or translational aspects of Nervous System Diseases for consideration by the Committee for Poster Presentation through Online Abstract Submission.

Authors are required to submit abstracts through Online Abstract Submission. Facsimile or email copy will NOT be accepted.

Submission Procedure
  1. Please register for the Conference (HERE) to receive the Registration ID; Or
  2. If you have already registered, use your registered email address & received Registration ID for online abstract submission (HERE).
  3. Abstracts shall be submitted on or before 21 January 2022 Hong Kong Time.
  4. For guidelines and sample template of the abstract, please click HERE.

Arrangement for Poster Presentation
  1. Abstract author is required to prepare an electronic poster (E-poster) for the abstract accepted by BRAIN 2022. All posters will be displayed on BRAIN 2022 Website throughout the Conference period and within one year after the Conference.
  2. Onsite poster display and presentation arrangement will be announced in due course.

Poster Presentation Award
  1. The top abstracts will be selected for oral presentation during the Conference. Certificates will be issued to all selected oral presentation posters.
  2. Winners for the Best Presentation Award will be awarded cash prizes. Posters are judged by members of the organizing committee and chairpersons and consideration is given to scientific rigour, contribution to the field, relevance to the themes and overall presentation.

SPONOSRHIP & EXHIBITION

Hybrid Exhibition will be held jointly with the Conference. This Conference provides a platform for sharing views and experience from world's leading experts in the fields of Neurosciences. It is indeed a perfect opportunity for the stakeholders in the industry to enhance corporate visibility in the fields and update with today's development. For further details on Sponsorship and Exhibition Opportunities, please contact the Conference Secretariat at brainconference@cuhk.edu.hk.

Virtual Exhibition
(in alphabetical order)

The Organising Committee wishes to thank all the following companies for their generous supports.
Boehringer Ingelheim (Hong Kong) LimitedX
Suites 1504-9, Great Eagle Centre
23 Harbour Road, Wanchai, Hong Kong
(+852) 2596 0033
(+852) 2827 0162
www.boehringer-ingelheim.com.hk
Boehringer Ingelheim (Hong Kong) Limited
DCH Auriga (HK) LimitedX
11/F., Wyler Centre I
202-210 Tai Lin Pai Road
Kwai Chung, NT, Hong Kong
(+852) 3619 2823
www.dchauriga.com
DCH Auriga (HK) Limited
Novartis Pharmaceuticals (HK) LimitedX
7/F, Citi Tower, One Bay East
83 Hoi Bun Road, Kwun Tong
Kowloon, Hong Kong
(+852) 2881 4424
(+852) 2159 7242
www.novartis.com
Novartis Pharmaceuticals (HK) Limited

Otsuka Pharmaceutical (H.K.) Ltd.X
21/F, East Exchange Tower
38 Leighton Road
Causeway Bay, Hong Kong
(+852) 2881 6299
(+852) 2577 5206
www.otsuka.hk/zh/cardio-page.php?yes=1
Otsuka Pharmaceutical (H.K.) Ltd.
Teva Pharmaceutical Hong Kong LimitedX
Unit 2303, 23/F., Mira Place Tower A
132 Nathan Road, Tsim Sha Tsui
(+852) 3701 9177
www.tevapharm.hk/en/hong-kong
Teva Pharmaceutical Hong Kong Limited

CONFERENCE INFORMATION

Date
25-26 February 2022 (Friday - Saturday)

Time Zone
All communicated times in the Scientific Programme are Hong Kong Time. Hong Kong is 8 hours ahead of Greenwich Mean Time (i.e. GMT + 8 hours).

Venue
10/F, CUHK Medical Centre
9 Chak Cheung Street, Shatin, New Territories, Hong Kong

Official Language
The official language of the Conference is English. There will be no translation provided.

Registration
All registrations should be made through the Online Registration.

Webcast
Conference will be webcasted for overseas participants via this website. It is highly recommended to join the webinar from the computer for the best experience. The webinar is NOT supported on the mobile version of web browsers.

Trade Exhibition
Physical and virtual exhibition of medical equipment, books and pharmaceutical brochures will be held during the Conference on 25 - 26 February 2022.

Letter of Invitation
The Organising Committee would be pleased to provide letters of invitation (without provisions of financial support) upon request. Please address your request to the Conference Secretariat.

Academic Accreditations (for local participants)
Continuing Medical Education (CME), Continuing Nursing Education (CNE) and Continuing Professional Development (CPD) accreditation will be applied from relevant Hong Kong colleges and associations.

Please kindly note that CNE is eligible for in-person attendance only (except Alzheimer‘s Disease session on 26 February).

Certificate of Attendance
E-Certificate of Attendance will be issued upon registration and attendance after the Conference via email.

Liability and Insurance
The Organiser is not responsible for injury or damage involving persons and property during the Conference. Participants are advised to make their own arrangements for their medical, travel and personal insurance. Equipment and all related display materials installed by Exhibitors / Sponsors are not insured by the Organiser, and the Organiser under no circumstances will be liable for any loss, damage or destruction caused to equipment, goods or property belonging to Exhibitors/Sponsors.

Disclaimer
Whilst every attempt is made to ensure that all aspects of the Conference as mentioned in this website will take place as scheduled, the Organising Committee reserves the right to make changes should the need arise.

TRANSPORTATION

CUHK Medical Centre
9 Chak Cheung Street, Shatin, New Territories, Hong Kong

By MTR
University Station (East Rail Line) (Exit B)

By Bus
43P, 82C, 87S, 87K, 99R, 263A, 272A, 272K, 289K, A47X (Airport Bus)

By Minibus
27A, 807A, 807B, 807K, 807P, 807S

By Car/ Taxi
1. Take the route via Tolo Highway;
2. Take Exit No. 4 Ma Liu Shui Entrance, heading to Pak Shek Kok, Science Park and Ma On Shan;
3. Take MTR University Station direction when arriving the roundabout.

CONTACT US

Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong

9/F Lui Che Woo Clinical Sciences Building
Prince of Wales Hospital, Shatin, Hong Kong

Tel: (852) 2895 3968/ 2674 7866

Fax: (852) 2295 4399

E-mail: brainconference@cuhk.edu.hk

Website: cu-brain.cuhk.edu.hk

Abstract Submission ( Required Fields )X

The email address should be the same as the email used to register the conference.

Your Registered Email
ABSTRACT DETAILS
Title
Authors
Institution
Country
Abstract
(Must not exceed 300 words)

Guidelines for Submission of Abstracts

Sample Abstract

Online Registration ( Required Fields ) X

CNE is eligible for in-person attendance only (except webinar session for Alzheimer's Disease on 26 February).

Format
Title
Surname
Given Name
Position
Department
Institution
Mailing Address
Region
Profession
Tel
Fax
Email
Confirm Email